|
KIF4B expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.503580E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.152000E-01 |
| Normal-vs-Stage2 |
1.327640E-01 |
| Normal-vs-Stage3 |
3.118800E-01 |
| Normal-vs-Stage4 |
3.590000E-02 |
| Stage1-vs-Stage2 |
2.797200E-01 |
| Stage1-vs-Stage3 |
7.779600E-01 |
| Stage1-vs-Stage4 |
6.518400E-02 |
| Stage2-vs-Stage3 |
3.827400E-01 |
| Stage2-vs-Stage4 |
5.883800E-01 |
| Stage3-vs-Stage4 |
1.131180E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.949810E-01 |
| Normal-vs-AfricanAmerican |
1.589200E-01 |
| Normal-vs-Asian |
5.460000E-02 |
| Caucasian-vs-AfricanAmerican |
3.706200E-01 |
| Caucasian-vs-Asian |
1.123360E-01 |
| AfricanAmerican-vs-Asian |
8.101200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.724400E-01 |
| Normal-vs-Female |
1.391030E-01 |
| Male-vs-Female |
8.280200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.186050E-01 |
| Normal-vs-Age(41-60Yrs) |
2.942400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.495050E-01 |
| Normal-vs-Age(81-100Yrs) |
2.473600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.897200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.770400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.901900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.722800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.580100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.413700E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.956400E-01 |
| Classical-VS-Follicular |
4.002500E-02 |
| Classical-VS-Other |
1.814000E-02 |
| Classical-VS-Normal |
4.982200E-02 |
| Tall-VS-Follicular |
8.001000E-01 |
| Tall-VS-Other |
6.587500E-02 |
| Tall-VS-Normal |
6.519800E-01 |
| Follicular-VS-Other |
7.381800E-02 |
| Follicular-VS-Normal |
7.479200E-01 |
| Other-VS-Normal |
1.609410E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.812000E-01 |
| Normal-vs-N1 |
2.681800E-01 |
| N0-vs-N1 |
7.263800E-01 |
|
|
